Drug Type CAR-T |
Synonyms B7-H3.TMI.ze CAR-T therapy(Albert Einstein College of Medicine) |
Target |
Mechanism CD276 modulators(CD276 antigen modulators), TMIGD2 modulators(transmembrane and immunoglobulin domain containing 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | 08 May 2024 |